The Turkey pharmaceutical market size reached US$ 7.81 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.23 Billion by 2032, exhibiting a growth rate (CAGR) of 4.50% during 2024-2032. The market is primarily driven by the expanding healthcare sector due to easy access to healthcare services, rising demand among the growing geriatric population, advancements in medical technology, and strategic investments by local and international pharmaceutical companies across the region.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 7.81 Billion |
Market Forecast in 2032
|
US$ 12.23 Billion |
Market Growth Rate 2024-2032 | 4.50% |
The Growing Aging population:
The demographic patterns in Turkey including population growth and an aging population, are influencing the pharmaceutical industry in Turkey. According to the Turkish Statistical Institute press release stating that 6,895,385 people were 65 years of age or older in 2017. This group increased by 22.6% during the next five years, to reach 8,451,669 individuals by 2022. The percentage of the population that is old grew throughout this time, rising from 8.5% in 2017 to 9.9% in 2022. In 2022, there were 44.4% men and 55.6% women among the old population. Moreover, the population forecasts indicate that the percentage of old people will likely continue to rise, reaching 12.9% by 2030, 16.3% by 2040, 22.6% by 2060, and 25.6% by 2080. These projections are escalating the demand for pharmaceutical products tailored to chronic disease management, geriatric care, and the overall healthcare needs of the geriatric population. This demographic shift has prompted pharmaceutical companies to innovate and develop medications that address age-related conditions such as cardiovascular diseases, diabetes, and arthritis.
Increased Access to Healthcare:
The Turkish pharmaceutical industry has been greatly influenced by the growth of healthcare services. According to ilac Endustrisi iseverenler Sendikasi (IEIS), pharmaceutical manufacturer of Turkiye, the value of Turkey's combined pharmaceutical and healthcare product market including sales from pharmacies and hospitals increased to TRY 121.6 billion in 2022, a noteworthy 78.8% growth. The market increased by 8.6% in terms of unit sales, reaching 2.82 Billion units. Additionally, a variety of products authorized by the Ministry of Health are available in the healthcare market, including prescription drugs, foods specifically designed for health, and conventional herbal remedies. Moreover, the expansion was further aided by goods that were authorized by the Ministry of Agriculture and Forestry, including food supplements, vitamins, and formulae, thus contributing to the market growth. According to the most current statistics available, the healthcare market had a 7.1% increase in units and a 28.8% increase in value in 2021, demonstrating strong expansion across several industry areas. Hence, there the easy availability of pharmaceuticals is increasing the need for pharmaceutical items, ranging from specialty drugs to basic therapies across Turkey.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on type and nature.
Type Insights:
The report has provided a detailed breakup and analysis of the market based on the type. This includes pharmaceutical drugs, (cardiovascular drugs, dermatology drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs, anti-infective drugs, metabolic disorder drugs, musculoskeletal disorder drugs, central nervous system drugs, oncology drugs, ophthalmology drugs, and respiratory diseases drugs) and biologics, (monoclonal antibodies (mabs), therapeutic proteins, and vaccines.
Nature Insights:
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes organic and conventional.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Marmara, Central Anatolia, Mediterranean, Aegean, Southeastern Anatolia, Blacksea, Eastern Anatolia.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | Billion US$ |
Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Types Covered |
|
Natures Covered | Organic, Conventional |
Regions Covered | Marmara, Central Anatolia, Mediterranean, Aegean, Southeastern Anatolia, Blacksea, Eastern Anatolia |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |